Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Xenoport Inc (NASDAQ:XNPT)

Monday’s trading has closed, but XNPT is being traded in the after-hours session. After-Hours quote »
4.29
Delayed Data
As of 4:00pm ET
 -0.37 / -7.94%
Today’s Change
3.35
Today|||52-Week Range
8.67
-21.86%
Year-to-Date
No recent news for Xenoport Inc.

Today’s Trading

Previous close4.66
Today’s open4.59
Day’s range4.19 - 4.63
Volume609,751
Average volume (3 months)1,407,918
Market cap$294.5M
Dividend yield--
Data as of 4:00pm ET, 02/08/2016

Growth & Valuation

Earnings growth (last year)+55.25%
Earnings growth (this year)-69.19%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+489.46%
P/E ratioNM
Price/Sales11.39
Price/Book3.19

Competitors

 Today’s
change
Today’s
% change
PGNXProgenics Pharmaceut...-0.26-6.18%
AKBAAkebia Therapeutics ...-0.29-3.90%
INFIInfinity Pharmaceuti...-0.23-4.02%
OMEDOncoMed Pharmaceutic...-0.10-1.07%
Data as of 4:00pm ET, 02/08/2016

Financials

Next reporting dateFebruary 18, 2016
EPS forecast (this quarter)-$0.31
Annual revenue (last year)$46.9M
Annual profit (last year)-$49.3M
Net profit margin-105.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Vincent J. Angotti
Chief Financial Officer &
Senior VP-Finance
William G. Harris
Corporate headquarters
Santa Clara, California

Forecasts

Partner Offers